Seer (SEER) Non Operating Income (2020 - 2026)
Seer (SEER) posted quarterly Non Operating Income of $429000.0 for Q1 2026, down 51.47% year-over-year from $884000.0 in Q1 2025, and down 69.77% quarter-over-quarter from $1.4 million in Q4 2025.
Seer (SEER) Non Operating Income (2020 - 2026) Analysis & Trends
Seer's Non Operating Income history runs 7 years deep, the most recent figure standing at $429000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 51.47% year-over-year to $429000.0; the TTM figure through Mar 2026 stood at $4.1 million (down 58.5% YoY), while the FY2025 annual figure was $4.6 million, down 66.23% from the prior year.
- Non Operating Income for Q1 2026 stood at $429000.0, down from $1.4 million in the prior quarter.
- The five-year high for Non Operating Income was $4.8 million in Q3 2023, with the low at $140000.0 in Q1 2022.
- The 5-year median for Non Operating Income is $1.8 million (2024), against an average of $2.4 million.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income surged 2390.0% in 2023, then sank 80.41% in 2025.
- Seer's Non Operating Income stood at $2.4 million in 2022, then jumped by 82.88% to $4.4 million in 2023, then tumbled by 58.4% to $1.8 million in 2024, then dropped by 23.05% to $1.4 million in 2025, then sank by 69.77% to $429000.0 in 2026.
- Business Quant data shows SEER's Non Operating Income at $429000.0 in Q1 2026, $1.4 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -49,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -49,000.00 |
| Mar 31, 2026 | 429,000.00 |
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 884,000.00 |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 4.25 Mn |
| Mar 31, 2024 | 4.51 Mn |
| Dec 31, 2023 | 4.43 Mn |
| Sep 30, 2023 | 4.76 Mn |
| Jun 30, 2023 | 4.51 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Dec 31, 2022 | 2.42 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 619,000.00 |
| Mar 31, 2022 | 140,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 46,000.00 |